First Financial Corp’s AstraZeneca AZN Stock Holding History

First Financial Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9	Closed	-$1.11K	–	350
2024 Q4	$1.11K	Hold	9	–	–	﹤0.01%	375
2024 Q3	$1.32K	Sell	9 -29	-76%	-$4.68K	﹤0.01%	419
2024 Q2	$5.85K	Sell	38 -129	-77%	-$19.4K	﹤0.01%	347
2024 Q1	$22.6K	Sell	167 -730	-81%	-$96.7K	0.01%	273
2023 Q4	$121K	Hold	897	–	–	0.06%	160
2023 Q3	$121K	Hold	897	–	–	0.07%	153
2023 Q2	$128K	Hold	897	–	–	0.08%	131
2023 Q1	$125K	Hold	897	–	–	0.08%	131
2022 Q4	$122K	Hold	897	–	–	0.07%	131
2022 Q3	$98K	Buy	897 +17	+2%	+$2.16K	0.07%	145
2022 Q2	$116K	Hold	880	–	–	0.08%	133
2022 Q1	$117K	Hold	880	–	–	0.07%	149
2021 Q4	$103K	Hold	880	–	–	0.06%	149
2021 Q3	$106K	Hold	880	–	–	0.07%	143
2021 Q2	$105K	Hold	880	–	–	0.07%	141
2021 Q1	$88K	Hold	880	–	–	0.06%	149
2020 Q4	$88K	Hold	880	–	–	0.06%	145
2020 Q3	$96K	Hold	880	–	–	0.08%	130
2020 Q2	$93K	Hold	880	–	–	0.08%	128
2020 Q1	$79K	Hold	880	–	–	0.07%	136
2019 Q4	$88K	Hold	880	–	–	0.06%	157
2019 Q3	$78K	Hold	880	–	–	0.06%	165
2019 Q2	$73K	Hold	880	–	–	0.06%	157
2019 Q1	$71K	Hold	880	–	–	0.05%	171
2018 Q4	$67K	Hold	880	–	–	0.05%	165
2018 Q3	$70K	Hold	880	–	–	0.05%	176
2018 Q2	$62K	Hold	880	–	–	0.04%	186
2018 Q1	$62K	Hold	880	–	–	0.04%	187
2017 Q4	$61K	Hold	880	–	–	0.04%	198
2017 Q3	$60K	Hold	880	–	–	0.04%	210
2017 Q2	$60K	Hold	880	–	–	0.04%	201
2017 Q1	$55K	Hold	880	–	–	0.03%	204
2016 Q4	$48K	Hold	880	–	–	0.03%	222
2016 Q3	$58K	Hold	880	–	–	0.03%	207
2016 Q2	$53K	Hold	880	–	–	0.03%	241
2016 Q1	$50K	Sell	880 -950	-52%	-$57.1K	0.03%	259
2015 Q4	$124K	Hold	1,830	–	–	0.07%	182
2015 Q3	$116K	Sell	1,830 -50	-3%	-$3.29K	0.07%	180
2015 Q2	$120K	Hold	1,880	–	–	0.06%	185
2015 Q1	$129K	Hold	1,880	–	–	0.07%	183
2014 Q4	$132K	Hold	1,880	–	–	0.07%	181
2014 Q3	$134K	Hold	1,880	–	–	0.07%	180
2014 Q2	$140K	Hold	1,880	–	–	0.07%	182
2014 Q1	$122K	Hold	1,880	–	–	0.06%	185
2013 Q4	$112K	Hold	1,880	–	–	0.05%	195
2013 Q3	$98K	Hold	1,880	–	–	0.05%	210
2013 Q2	$89K	Buy	+1,880	New	+$95.7K	0.04%	214

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

First Financial Corp's AZN Position: Q1 2025 in Review

First Financial Corp sold out of AstraZeneca (AZN) in Q1 2025, closing a stake of 9 shares — an estimated $1.11K sold.

First Financial Corp first reported a position in AZN in Q2 2013 and held it in 47 quarters. The position peaked at $140K in Q2 2014. 1,251 funds tracked by Wall St. Rank hold AZN as of Q1 2025.

First Financial Corp reported no remaining AstraZeneca position as of Q1 2025 after selling out during the quarter.
First Financial Corp sold 9 AstraZeneca shares in Q1 2025, an estimated $1.11K.
First Financial Corp first reported a position in AstraZeneca in Q2 2013 and held it in 47 quarters.
First Financial Corp's AstraZeneca position peaked at $140K in Q2 2014.
1,251 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on First Financial Corp's 13F filing for Q1 2025, filed 10 Apr 2025.